Monashee Investment Management LLC Magenta Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$6.52 - $8.94 $652,000 - $894,000	-100,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$6.18 - $10.76 $618,000 - $1.08 Million	100,000 New	100,000 $751,000
Q3 2018 Nov 13, 2018	SELL	$11.32 - $15.7 $1.56 Million - $2.16 Million	-137,500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$13.5 - $14.52 $1.86 Million - $2 Million	137,500 New	137,500 $1.86 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.